A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.
Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.
Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City. “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."
For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.
cheatsheet, End of Life, Facts and Figures, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports
Alzheimer’s disease is nearly as lethal as the two biggest killers in the United States, according to a new study. Approximately 500,000 people died i...
Appropriations Subcommittee Chairman Tom Harkin (D-Iowa) asked at a hearing about Alzheimer’s funding what the National Institutes of Health is doing ...
All About Alzheimer’s: News from the National Institute on Aging, an Educational Buddy Program & More
The National Institute on Aging has released an updated version of its Alzheimer’s Disease Progress report.The initiatives, objectives, and advances d...
Experts and a Comedian Implore Sympathetic Senators to Keep Finances Flowing for Alzheimer’s Research
cheatsheet, Health and Wellness, Health Care, Hearings, Memory Care Best Practices and Research, Memory Care Education
Alzheimer’s disease can affect people at any income level said Appropriations Chairwoman Barbara Mikulski at a subcommittee hearing on the rising cost...
Clinical Quality and Quality Care Delivery, Federal Agency Activity, Health and Wellness, Health Care
The Centers for Medicare & Medicaid Services recently announced that for the first time quality measures have been added to a website designed to help...
Facts and Figures, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports
Scientists have found when adding compounds called advanced glycation end products, or AGEs, to the lifelong diets of laboratory mice, the animals dev...
Health and Wellness, Health Care, Medication Management
Five large national pharmacy chains overseeing more than 20,000 stores have agreed to use the Blue Button health information sharing initiative starte...
End of Life, Facts and Figures, Health and Wellness, Medication Management, Memory Care Best Practices and Research, Memory Care Education, Reports
Nutrition is an important factor when considering the health of seniors with dementia, with a new report finding that up to 45 percent of dementia suf...
All About Alzheimer’s: 10 Things to Learn from Alzheimer’s Residents, Brain Implants, China Ill Prepared and Drugs on the Horizon
Facts and Figures, Memory Care Best Practices and Research, Memory Care Education, Reports, Science and Technology
A volunteer at Clare Bridge, a Brookdale Senior Living community in Overland Park, Kansas, writes in the Huffington Post about the 10 things people wi...
Falls Prevention, Federal Agency Activity, Health and Wellness
President Obama recently signed the fiscal year 2014 bill funding the federal government, including $5 million from the Prevention and Public Health F...